Warning: The NCBI web site requires JavaScript to function. more...
Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations.
Lehmann B.
Child Adolesc Psychiatry Ment Health. 2008 Dec 8;2(1):37.
Related citations
European Union. Ethical considerations for clinical trials on medicinal products conducted with the paediatric population.
[No authors listed]
Eur J Health Law. 2008 Jul;15(2):223-50.
Stem cell transplantation in children: how to design a new study.
Corbacioglu S; EBMT Paediatric Working Party.
Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S30-4.
Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population--a field report.
Welzing L, Harnischmacher U, Weyersberg A, Roth B.
Eur J Pediatr. 2007 Nov;166(11):1169-76. Epub 2007 Feb 27.
[Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands].
Lehmann B, Mentzer D, Fischer T, Mallinckrodt-Pape K.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Apr;52(4):410-6. German.
[Clinical trials in Germany and in the EU in the new legislative environment. An analysis from the industry's point of view].
Heidenreich K, Möritz A, Löffler H, Oberle-Rolle B.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Apr;48(4):415-22. German.
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ, Aislaitner G, Pirozynski M, Mifsud S.
Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000. Review.
[Harmonisation of regulatory requirements for clinical trials on medicinal products for human use in the Directive 2001/20/EC and complementary guidance. Implementation of the 12th Law Amending the German Drug Law].
Geisler I, Hofmann HP, Nickel L.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Feb;48(2):141-6. German.
The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
Rocchi F, Tomasi P.
Pharmacol Res. 2011 Sep;64(3):169-75. Epub 2011 Mar 3. Review.
Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G.
Eur J Clin Pharmacol. 2002 Nov;58(8):495-500. Epub 2002 Sep 25.
The European Regulation on medicines for paediatric use.
Dunne J.
Paediatr Respir Rev. 2007 Jun;8(2):177-83. Epub 2007 May 30. Review.
Emergency research without consent under Polish law.
Rózyńska J, Czarkowski M.
Sci Eng Ethics. 2007 Sep;13(3):337-50. Epub 2007 Sep 14.
The European paediatric legislation: benefits and perspectives.
Rocchi F, Paolucci P, Ceci A, Rossi P.
Ital J Pediatr. 2010 Aug 17;36:56.
[The implementation of European directives into national law, demonstrated by the example of the EC Tissues and Cells Directive 2004/23/EC].
von Auer F.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jul;51(7):757-63. German.
American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology.
J Clin Oncol. 2003 Jun 15;21(12):2377-86. Epub 2003 Apr 29.
[Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)].
Vos EJ, Huitema AD.
Ned Tijdschr Geneeskd. 2006 Sep 23;150(38):2104-7. Dutch.
Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
Grienenberger A.
J Biolaw Bus. 2004;7(4):58-63.
Children in clinical trials: survey on the current situation in paediatric university clinics in Germany.
Khan-Boluki J, Hundt F.
Ger Med Sci. 2008 Mar 10;6:Doc01.
EU Water Framework Directive and Stockholm Convention: can we reach the targets for priority substances and persistent organic pollutants?
Fuerhacker M.
Environ Sci Pollut Res Int. 2009 Aug;16 Suppl 1:S92-7. Epub 2009 Apr 1.
Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective.
Auby P.
Child Adolesc Psychiatry Ment Health. 2008 Dec 8;2(1):38.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on